Monday, September 17, 2012

The Morning Call-Can you say 'insanity?'



Share/Bookmark
I don’t have to tell you that it was all wine and roses last week.

The Market
Technical
Monday Morning Chartology

 The S&P is now in a short term uptrend (1397-1474) and an intermediate term uptrend (1303-1863). The next visible resistance level, other than the upper boundaries of the two uptrends, is 1576.

Tuesday, September 11, 2012

GE Phase 3 Results Flutemetamol (18F)



Share/Bookmark
GE Healthcare today announced pooled results from phase III brain autopsy and biopsy studies on the investigational PET amyloid imaging agent, [18F]Flutemetamol

All American Investor

GE Healthcare today announced pooled results from phase III brain autopsy and biopsy studies on the investigational PET amyloid imaging agent, [18F]flutemetamol, which showed a strong concordance between [18F]flutemetamol images and Alzheimer’s disease-associated beta amyloid brain pathology.

[18F]Flutemetamol is a PET imaging agent being developed by GE Healthcare for the detection of beta amyloid deposits in the brain. The data from the phase III studies further confirm the potential application of [18F]flutemetamol as an imaging agent to detect beta amyloid plaques.

The data was presented at the 16th Congress of the European Federation of Neurological Societies (EFNS) in Stockholm, Sweden, and provide support for an application for regulatory approval of [18F]flutemetamol, which is intended to be filed in the US and EU later this year.

Saturday, September 8, 2012

The Market-Disciplined Investing Sept 8



Share/Bookmark
Technical

This week, the indices (DJIA 13306, S&P 1437) closed within their intermediate term uptrends [12316-17316, 1298-1878]. But as you know, the big technical event was the S&P punching through the upper boundary of its short term trading range (1266-1422) on Thursday followed by similar action in the Dow on Friday [12022-13302]. This activated our time and distance discipline on both; and at Friday’s close, the S&P has been above the 1422 resistance level for two days, the DJIA one day. In the absence of any retracement, the breaks will be confirmed at the close Tuesday/Wednesday.

This leaves me sitting on my hands awaiting confirmation of this potential break but still somewhat doubtful that it will succeed based on continuing negative readings in a number of breadth indicators including the flow of funds, on balance volume and our own internal indicator.